Liposomes in Treatment of Infectious Diseases
Overview
Affiliations
In reviewing the literature about the potential of liposomes in the therapy of infections caused by protozoa, bacteria, fungi and viruses, it can be concluded that liposomal encapsulation may improve the therapeutic index of anti-infectious drugs. The improved therapeutic index may be a result of a reduction in drug toxicity and/or an enhanced drug delivery at the intracellular site of infection. Furthermore, attention is paid to the therapeutic utility of liposome-encapsulated immunomodulators in treatment of infections.
MEHTA R Antimicrob Agents Chemother. 1996; 40(8):1893-902.
PMID: 8843300 PMC: 163436. DOI: 10.1128/AAC.40.8.1893.
Lokerse A, ten Kate M, Melissen P, van Vianen W, Van Etten E Eur J Clin Microbiol Infect Dis. 1993; 12 Suppl 1:S61-7.
PMID: 8477767 DOI: 10.1007/BF02389881.
Duzgunes N, Perumal V, Kesavalu L, Goldstein J, Debs R, GANGADHARAM P Antimicrob Agents Chemother. 1988; 32(9):1404-11.
PMID: 3196002 PMC: 175877. DOI: 10.1128/AAC.32.9.1404.
Lokerse A, Roerdink F Antimicrob Agents Chemother. 1988; 32(10):1560-4.
PMID: 3142339 PMC: 175919. DOI: 10.1128/AAC.32.10.1560.
Peeters P, de Leest K, Eling W, Crommelin D Pharm Res. 1989; 6(9):787-93.
PMID: 2682591 DOI: 10.1023/a:1015927614920.